A multicenter analysis focusing on acquired BRAFi resistance reported that 13% of the examined patient cohort had increasing BRAF gene copy number during tumor progression compared to the CNA status of the gene at the time of diagnosis [45]. Here, BRAF is linked to neoplasm.